Diagnosis of melanoma and solar lentigo by nucleic acid analysis
The present invention provides methods for diagnosing melanoma and/or solar lentigo in a subject by analyzing nucleic acid molecules obtained from the subject. The present invention also provides methods for distinguishing melanoma from solar lentigo and/or dysplastic nevi and/or normal pigmented skin. The methods include analyzing expression or mutations in epidermal samples, of one or more skin markers. The methods can include the use of a microarray to analyze gene or protein profiles from a sample.
1. A method for non-invasive analysis of a skin sample, the method comprising:
obtaining a skin sample collected using at least one adhesive tape, wherein the adhesive tape comprises:
an adhesive matrix on a first surface of a collection area; and
a skin sample adhered to the adhesive matrix, wherein the adhesive tape comprises a demarcation indicative of a region to be processed;
removing the demarcated region from the collection area; and
analyzing one or more target genes in the removed region of the collection area comprising the skin sample.
2. The method of claim 1 , wherein the demarcation is representative of an outline of a skin lesion.
3. The method of claim 2 , wherein the demarcation is approximately 1 millimeter from the outline of the skin lesion.
4. The method of claim 2 , wherein the demarcation is created by a surgical skin marker or a water soluble marker.
5. The method of claim 1 , wherein the demarcation comprises marker on a second surface of the collection area.
6. The method of claim 1 , wherein the collection area comprises a transparent material.
7. The method of claim 1 , wherein the skin sample is collected using a plurality of adhesive tapes.
8. The method of claim 1 , wherein the analyzing comprises detection of RNA and/or DNA.
9. The method of claim 1 , further comprising deriving information related to a disease wherein the deriving is based on the quantified expression levels of the one or more target genes.
10. The method of claim 9 , wherein the disease comprises a cancer.
11. The method of claim 9 , wherein the information related to the disease comprises an identification of a disease state, a likelihood of treatment success for a disease state, an identification of progression of a disease state, or an identification of a disease stage.
12. The method of claim 1 , further comprising providing a strip, wherein the adhesive matrix comprising the skin sample is placed onto the strip with the skin sample facing down.
13. The method of claim 12 , wherein the strip is stored at −20 degrees Celsius prior to analysis.
14. The method of claim 1 , wherein the demarcation is made by a user.
15. The method of claim 14 , wherein the user is a patient.
16. The method of claim 1 , wherein the skin sample comprises at least 200 μg of RNA.
17. The method of claim 1 , wherein the analyzing comprises quantifying expression levels of the one or more target genes.
18. The method of claim 1 , wherein the removing comprises cutting the demarcated region from the collection area.
19. A method for non-invasive collection and analysis of a skin sample, the method comprising:
receiving an adhesive skin sample collection kit comprising at least one adhesive tape,
wherein the adhesive tape comprises:
an adhesive matrix on a first surface of a collection area; and
a skin sample adhered to the adhesive matrix, wherein the adhesive tape comprises a demarcation indicative of a region to be processed; and
quantifying expression levels of one or more target genes in the skin sample;
wherein any one of (i)-(iii):
(i) wherein the demarcation is representative of an outline of a skin lesion, and the demarcation is approximately 1 millimeter from the outline of the skin lesion,
(ii) the method further comprising providing an adhesive strip, wherein the adhesive matrix comprising the skin sample is placed onto the adhesive strip with the skin sample facing down, or
(iii) wherein the demarcation is representative of an outline of a skin lesion, and the demarcation is created by a surgical skin marker or a water soluble marker.
20. The method of claim 19 , wherein the demarcation is representative of an outline of a skin lesion, and the demarcation is approximately 1 millimeter from the outline of the skin lesion.
21. The method of claim 19 , comprising providing an adhesive strip, wherein the adhesive matrix comprising the skin sample is placed onto the adhesive strip with the skin sample facing down.
22. The method of claim 21 , wherein the adhesive strip is stored at −20 degrees Celsius prior to analysis.
23. The method of claim 19 , wherein the demarcation is representative of an outline of a skin lesion, and the demarcation is created by a surgical skin marker or a water soluble marker.